Adagio Medical Holdings, Inc. (ADGM)
NASDAQ: ADGM · Real-Time Price · USD
1.930
+0.110 (6.04%)
At close: Nov 13, 2026, 4:00 PM EST
1.870
-0.060 (-3.11%)
Pre-market: Nov 16, 2026, 7:12 AM EST
Adagio Medical Holdings Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
41
Market Cap
1.43M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 602.00K | 302.00K | 100.67% |
| Dec 31, 2023 | 300.00K | 111.00K | 58.73% |
| Dec 31, 2022 | 189.00K | -81.00K | -30.00% |
| Dec 31, 2021 | 270.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Baird Medical Investment Holdings | 24.49M |
| Vivos Therapeutics | 20.90M |
| WORK Medical Technology Group LTD | 10.72M |
| Nuwellis | 9.01M |
| Beyond Air | 8.19M |
| Tenon Medical | 5.57M |
| 20/20 Biolabs | 2.04M |
| Co-Diagnostics | 858.89K |
ADGM News
- 5 days ago - Adagio Medical provides business update on execution of FULCRUM-VT IDE study - TheFly
- 6 days ago - Adagio Medical Provides Business Update: 22 Patients Treated with Next-Generation vCLAS™ Ultra System as FULCRUM-VT IDE Sub-Study Advances - Business Wire
- 6 days ago - Adagio Medical Holdings Proxy statement: Proxy filing - Filings
- 9 days ago - Adagio Medical Holdings Inc trading halted, news pending - TheFly
- 23 days ago - Adagio Medical Holdings Transcript: EGM 2026 - Transcripts
- 4 weeks ago - Adagio Medical Holdings Proxy statement: Proxy filing - Filings
- 6 weeks ago - Adagio Medical Holdings Proxy statement: Proxy filing - Filings
- 7 weeks ago - Adagio Medical announces review of strategic alternatives - TheFly